Source: BioSpace

IvexSol: Cellares to tackle key roadblock in cell therapy manufacturing with new partner iVexSol

Cellares Corporation, a life science technology company leading the way in cell therapy manufacturing automation, and iVexSol Inc., a company developing transformative viral vector manufacturing capabilities, today announced a strategic partnership to solve key challenges with viral vector manufacturing in order to accelerate access to life-saving therapies.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Rodney L Rietze's photo - Co-Founder & CEO of IvexSol

Co-Founder & CEO

Rodney L Rietze

CEO Approval Rating

90/100

Read more